The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | L | Antineoplastic and immunomodulating agents | |
| 2 | L01 | Antineoplastic agents | |
| 3 | L01C | Plant alkaloids and other natural products | |
| 4 | L01CD | Taxanes | |
| 5 | L01CD04 | Cabazitaxel |
| Active Ingredient | Description | |
|---|---|---|
| Cabazitaxel |
Cabazitaxel is an antineoplastic agent that acts by disrupting the microtubular network in cells. Cabazitaxel binds to tubulin and promotes the assembly of tubulin into microtubules while simultaneously inhibiting their disassembly. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CABAZITAXEL ACCORD Concentrate for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC | |
| JEVTANA Concentrate and solvent for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
